← European Medicine Shortage Tracker · all medicines

Dopamina grifols shortage — availability across Europe

Dopamina grifols currently has availability issues reported in 1 European register: Spain.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Shortage  ATC — · also listed as: DOPAMINA GRIFOLS · data refreshed 7 August 2026

Key facts

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Dopamina grifols, covering 1 affected product presentation. The longest-running open report was filed in Spain on 2020-07-20 and has now been open for about 73 months. Registers in Spain indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇪🇸 SpainShortage
DOPAMINA GRIFOLS 200 mg SOLUCIÓN INYECTABLE, 6 ampollas de 5 ml
2020-07-20Se puede solicitar como medicamento extranjero.
Alternatives: Se puede solicitar como medicamento extranjero. https://www.aemps.gob.es/medicamentos-de-uso-humano/acceso-a-medicamentos-en-situaciones-especiales/
register ↗

Full report history (1 register entry)

Every individual register entry for Dopamina grifols in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇪🇸 ESDOPAMINA GRIFOLS 200 mg SOLUCIÓN INYECTABLE, 6 ampollas de 5 mlShortage2020-07-20Se puede solicitar como medicamento extranjero.

Frequently asked

Is Dopamina grifols currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Spain. Availability is national — a shortage in one country does not mean it is short everywhere.

Are there alternatives to Dopamina grifols?

1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Dopamina grifols availability data come from?

Directly from the official medicines-agency register that lists Dopamina grifols: AEMPS CIMA (Spain). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Dopamina grifols — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/dopamina-grifols/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Dopamina grifols availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/dopamina-grifols/">Dopamina grifols shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Dopamina grifols: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.